AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells medical devices for cardiac surgery. Its primary focus is on surgical ablation of cardiac tissue to treat arrhythmias, exclusion of the left atrial appendage, and temporary pain relief via nerve ablation. Key products include the Isolator Synergy Ablation System clamps, multifunctional pens, linear ablation devices, the cryoICE Cryoablation System, EPi-Sense Systems for atrial fibrillation, and the AtriClip System for left atrial appendage closure. The company also offers the LARIAT System for soft-tissue closure, Lumitip dissectors, Glidepath guides, and Subtle Cannulas. These devices are used by medical centers globally to treat conditions such as atrial fibrillation and to manage post-surgical pain.

AtriCure, Inc. is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol ATRC. Its shares trade in US Dollars (USD), reflecting its primary listing in the United States. The company is headquartered in the United States and operates within the US market, though its products are sold to medical centers globally.

AtriCure operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This means the company designs, manufactures, and sells specialized medical devices used by healthcare professionals. Its products are primarily used in cardiac surgery, including devices for tissue ablation, left atrial appendage management, and nerve pain relief. As a medical instruments supplier, AtriCure competes in a regulated market focused on improving surgical outcomes and patient recovery.

AtriCure, Inc. is headquartered in the United States, though the exact city is not specified in the available data. The company serves medical centers globally, marketing and selling its products through independent distributors and direct sales personnel. Its devices are used in cardiac surgeries worldwide, with a focus on treating conditions like atrial fibrillation and providing temporary pain relief through cryoablation. The company's global reach allows it to supply hospitals and clinics with innovative surgical instruments for cardiac care.